81 – 90 of 372
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
- Contribution to journal › Article
-
Mark
A European Registry Evaluating Symptomatic Effectiveness of Pharmacologically Treated Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Enlargement : Lessons Learned
- Contribution to journal › Article
-
Mark
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
- Contribution to journal › Article
-
Mark
A retrospective study assessing the accuracy of [18F]–fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node dissection
- Contribution to journal › Article
-
Mark
Identification of a serum biomarker signature associated with metastatic prostate cancer
- Contribution to journal › Article
-
Mark
Contemporary use of phytotherapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia : results from the EVOLUTION European registry
- Contribution to journal › Article
-
Mark
Quality of life with pharmacological treatment in patients with benign prostatic enlargement : results from the Evolution European Prospective Multicenter Multi-National Registry Study
- Contribution to journal › Article
-
Mark
Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category : results from the LAParoscopic prostatectomy robot and open trial
- Contribution to journal › Article
-
Mark
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
- Contribution to journal › Letter
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
- Contribution to journal › Article
